XML 165 R42.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Debt obligations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Schedule of Short-term Debt |
a. | Short-term debt:
|  |  |  |  |  |  |  | December 31, |
|  | Weighted average interest rate as of December 31, 201 9 |  |  | Maturity |  |  | 2019 |  |  | 2018 |
|  |  |  |  |  |  |  | (U.S. $ in millions) |
Bank and financial institutions |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2 |
Convertible debentures |  |  | 0.25 % |  |  |  | 2026 |  |  |  | 514 |  |  |  | 514 |
Current maturities of long-term liabilities |  |  | 1,831 |  |  |  | 1,700 |
Total short term debt |  | $ | 2,345 |  |  | $ | 2,216 |
Schedule of Senior Notes and Loans |
|  | Weighted average interest rate as of December 31, 201 9 |  |  | Maturity |  |  | December 31, 2019 |  |  | December 31, 2018 |
|  | % |  |  |  |  |  | (U.S. $ in millions) |
Senior notes EUR 1,010 million (2) |  |  | 0.38 | % |  |  | 2020 |  |  | $ | 1,131 |  |  | $ | 1,897 |
Senior notes EUR 1,500 million |  |  | 1.13 | % |  |  | 2024 |  |  |  | 1,673 |  |  |  | 1,707 |
Senior notes EUR 1,300 million |  |  | 1.25 | % |  |  | 2023 |  |  |  | 1,451 |  |  |  | 1,480 |
Senior notes EUR 900 million |  |  | 4.50 | % |  |  | 2025 |  |  |  | 1,008 |  |  |  | 1,029 |
Senior notes EUR 750 million |  |  | 1.63 | % |  |  | 2028 |  |  |  | 833 |  |  |  | 850 |
Senior notes EUR 700 million |  |  | 3.25 | % |  |  | 2022 |  |  |  | 784 |  |  |  | 801 |
Senior notes EUR 700 million |  |  | 1.88 | % |  |  | 2027 |  |  |  | 782 |  |  |  | 798 |
Senior notes EUR 1,000 million (4) |  |  | 6.00 | % |  |  | 2025 |  |  |  | 1,120 |  |  |  | — |
Senior notes USD 1,000 million (5) |  |  | 7.13 | % |  |  | 2025 |  |  |  | 1,000 |  |  |  | — |
Senior notes USD 3,500 million |  |  | 3.15 | % |  |  | 2026 |  |  |  | 3,494 |  |  |  | 3,493 |
Senior notes USD 1,475 million (3) |  |  | 2.20 | % |  |  | 2021 |  |  |  | 1,474 |  |  |  | 2,997 |
Senior notes USD 3,000 million |  |  | 2.80 | % |  |  | 2023 |  |  |  | 2,995 |  |  |  | 2,993 |
Senior notes USD 1,556 million (1) |  |  | 1.70 | % |  |  | 2019 |  |  |  | — |  |  |  | 1,700 |
Senior notes USD 2,000 million |  |  | 4.10 | % |  |  | 2046 |  |  |  | 1,985 |  |  |  | 1,985 |
Senior notes USD 1,250 million |  |  | 6.00 | % |  |  | 2024 |  |  |  | 1,250 |  |  |  | 1,250 |
Senior notes USD 1,250 million |  |  | 6.75 | % |  |  | 2028 |  |  |  | 1,250 |  |  |  | 1,250 |
Senior notes USD 844 million |  |  | 2.95 | % |  |  | 2022 |  |  |  | 856 |  |  |  | 860 |
Senior notes USD 789 million |  |  | 6.15 | % |  |  | 2036 |  |  |  | 782 |  |  |  | 782 |
Senior notes USD 700 million |  |  | 2.25 | % |  |  | 2020 |  |  |  | 700 |  |  |  | 700 |
Senior notes USD 613 million |  |  | 3.65 | % |  |  | 2021 |  |  |  | 618 |  |  |  | 621 |
Senior notes USD 588 million |  |  | 3.65 | % |  |  | 2021 |  |  |  | 587 |  |  |  | 587 |
Senior notes CHF 350 million |  |  | 0.50 | % |  |  | 2022 |  |  |  | 361 |  |  |  | 356 |
Senior notes CHF 350 million |  |  | 1.00 | % |  |  | 2025 |  |  |  | 362 |  |  |  | 356 |
Fair value hedge accounting adjustments |  |  |  |  |  |  |  |  |  |  | — |  |  |  | (9 | )
Total senior notes |  |  | 26,496 |  |  |  | 28,483 |
Other long-term debt |  |  | 1.13 | % |  |  | 2026 |  |  |  | 1 |  |  |  | 12 |
Less current maturities |  |  | (1,831 | ) |  |  | (1,700 | )
Derivative instruments |  |  | — |  |  |  | 9 |
Less debt issuance costs |  |  | (103 | ) |  |  | (104 | )
Total senior notes and loans |  | $ | 24,562 |  |  | $ | 26,700 |
(1) | During the first six months of 2019, Teva repurchased and canceled approximately $144 million principal amount of its $1,700 million 1.7% senior notes due in July 2019. In July 2019, Teva repaid at maturity $1,556 million of its 1.7% senior notes.
(2) | In December 2019, Teva consummated an early redemption of 650 million Euro of its 1,660 million Euro 0.375% senior notes due in July 2020.
(3) | In November 2019, Teva consummated a cash tender offer for its $3,000 million 2.2% senior notes due in July 2021. As a result of the offer, Teva redeemed $1,525 million aggregate principal amount of this senior note.
(4) | In November 2019, Teva Pharmaceutical Finance Netherlands II B.V, a Teva finance subsidiary, issued senior notes in an aggregate principal amount of 1,000 million Euro bearing 6.0% annual interest and due January 2025.
Required Annual Principal Payments of Long-term Debt, Excluding Debt Issuance Cost |
|  | December 31, 2019 |
|  | (U.S. $ in millions) |
2021 |  | $ | 2,679 |
2022 |  |  | 2,002 |
2023 |  |  | 4,446 |
2024 |  |  | 2,923 |
2025 and thereafter |  |  | 13,131 |
|  | $ | 25,181 |

X
- Definition A schedule of data and information pertaining to long-debt instruments or arrangements, excluding convertible debt, that includes identification, terms, features, collateral requirements and other information necessary to a fair presentation. + References No definition available. + Details
Name: | teva_LongTermDebtExcludingConvertibleDebtTableTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 + Details
Name: | us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfShortTermDebtTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration